¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"complement profile"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
assumed velocity profile
°¡»ó ¼Óµµ ºÐÆ÷ »óÅÂ
dose profile
¼±·® Ãø¸éµµ
emergence profile
ÃâÇö Ãø¸ð, ÃâÇö À±°û
field profile
ÀÚÀå Ãø¸é »ó
heating and cooling temperature-place-time profile
°¡¿ ¹× ³Ã°¢ ¿Âµµ-À§Ä¡-½Ã°£ Çü
profile facial
¾È¸é Ãø¸éµµ
profile test
ÇÁ·ÎÆÄÀÏ °Ë»ç
slice profile
ÀýÆí Ãø¸éµµ
straight- jawed profile
Á¤À§¾Ç ¿· ¸ð½À
complement activation
º¸Ã¼ Ȱ¼º ÀÛ¿ë, º¸Ã¼ Ȱ¼ºÈ
complement consumption test
º¸Ã¼ ¼Òºñ ½ÃÇè
complement fixation inhibition test
º¸Ã¼ °íÁ¤ ÀúÇØ ½ÃÇè
complement fixation test
º¸Ã¼ °áÇÕ ½ÃÇè, º¸Ã¼ °áÇÕ °Ë»ç, º¸Ã¼ °íÁ¤ °Ë»ç
complement fixing antibody
º¸Ã¼ °áÇÕ Ç×ü
complement splitting
º¸Ã¼ ºÐÇØ
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¼³¸í
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½